Group activity

By Svea Herbst-Bayliss and Michael Erman Oct 10 (Reuters) - The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two...